Triple‐Enzyme Mimetic Manganese Nanozyme with Redox‐Adaptive Catalysis for Synergistic MSU Degradation and Inflammation Resolution in Acute Gout
Advanced Healthcare Materials · 2025-09 · 14 (24)
DOI: 10.1002/adhm.202502180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 26.06.2025. Verfasst von Yuxuan Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Metastable Materials Science and Technology, Yanshan University, Qinhuangdao, 066004, China. Hauptthemen laut MEDLINE: Manganese, Gout, Uric Acid, Inflammation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Science Foundation of China, Shenzhen Science and Technology Research, Development and Reform Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Acute gout, characterized by recurrent inflammatory flares caused by monosodium urate (MSU) crystal deposition, presents a therapeutic challenge due to the limited efficacy of current drugs in concurrently eliminating MSU crystals and resolving inflammation. To overcome this, a manganese‐based nanozyme derived from a ZIF‐8 metal‐organic framework (MOF) is developed, which is designed to avoid the reliance on precious metals seen in existing urate oxidase‐mimetic systems. By leveraging competitive coordination between zinc and manganese during MOF synthesis, atomic‐level dispersion of manganese active sites with precise modulation of the Mn 4+ /Mn 2+ redox equilibrium is achieved. Coupled with optimized pyrrolic/graphitic nitrogen configurations, the nanozyme demonstrates triple enzymatic activities: urate oxidase‐like activity for uric acid degradation (preventing MSU crystallization), catalase‐like activity for H 2 O 2 scavenging, and superoxide dismutase‐like activity to alleviate oxidative stress. Notably, the nanozyme directly destabilizes preformed MSU crystals via surface charge modulation and lattice disruption. In an acute gout model, the nanozyme surpasses colchicine in accelerating MSU clearance—through simultaneous dissolution of existing crystals and inhibition of new formation—while reducing inflammatory cytokine levels without systemic toxicity. This work introduces a redox‐adaptive nanozyme design strategy for managing crystalopathies, providing a dual‐action solution to combat both MSU‐driven inflammation and crystallization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Metastable Materials Science and Technology, Yanshan University, Qinhuangdao, 066004, China.
- Research Center for Human Tissues & Organs Degeneration, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
- Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, Shenzhen, 518055, China.
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- Orthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
ORCID-Profile: Guocheng Wang
Förderung
- National Science Foundation of China
- Shenzhen Science and Technology Research
- Development and Reform Commission of Shenzhen Municipality
- National Natural Science Foundation of China
Zitieren
APA
Lin, Y., Zhu, Z., Xu, Z., Chen, J., Li, Z., Huang, H., Zhang, Y., Chen, D., Liang, B., & Wang, G. (2025). Triple‐Enzyme Mimetic Manganese Nanozyme with Redox‐Adaptive Catalysis for Synergistic MSU Degradation and Inflammation Resolution in Acute Gout. Advanced Healthcare Materials, 14(24). https://doi.org/10.1002/adhm.202502180
Vancouver
Lin Y, Zhu Z, Xu Z, Chen J, Li Z, Huang H, et al. Triple‐Enzyme Mimetic Manganese Nanozyme with Redox‐Adaptive Catalysis for Synergistic MSU Degradation and Inflammation Resolution in Acute Gout. Advanced Healthcare Materials. 2025;14(24). doi:10.1002/adhm.202502180
BibTeX
@article{Lin2025,
author = {Lin, Yuxuan and Zhu, Zhenglin and Xu, Zhengjiang and Chen, Junkang and Li, Zhiqiang and Huang, Hui and Zhang, Yuan and Chen, Di and Liang, Bo and Wang, Guocheng},
title = {Triple‐Enzyme Mimetic Manganese Nanozyme with Redox‐Adaptive Catalysis for Synergistic MSU Degradation and Inflammation Resolution in Acute Gout},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {24},
doi = {10.1002/adhm.202502180}
}
EUVIMED